Although activation of these kinases was unexpected, other authors have shown similar effects of Dp44mT in prostate cancer cells (Dixon et al., 2013), and we have previously demonstrated the activation of AKT and induction of a stress response in DpC-treated SH-SY5Y cells (Macsek et al., 2022). The gene discussed is AKT1; the disease is Familial prostate cancer.